bioRxivBiophysicsPreprint
Buoyant mass reveals distinct T cell states predictive of checkpoint response
Jiaquan YuiD, Ye ZhangiD, Sarah M. DuquetteiD, Robert J. KimmerlingiD, James C. Kostas, Krystal K. LumiD, Rachel LaBella, Selim OlçumiD, Madeleine Vacha, Steve Wasserman, Reginald Aikins, Katie Katsis, Thomas R. UsherwoodiD, Sonia CoheniD, Teresa DinteriD, Aleigha Lawless, Tatyana Y. SharovaiD, Mark M. StevensiD, Gianfranco L. Yee, Weida WuiD, Stefani SprangeriD, Teemu P. MiettineniD, I. M. Ileana M Cristea, Genevieve Marie BolandiD, Scott R. ManalisiD
Abstract
T cells are central to immune defense, yet existing molecular and phenotypic assays do not fully capture a cells intrinsic immune potential. Here we show that a single physical property, buoyant mass, reveals hidden heterogeneity within phenotypically similar, resting CD8+ T cells. Using suspended microchannel resonator measurements, we identify two distinct populations: "light" cells, enriched for mitochondrial content but prone to delayed activation and exhaustion, and "heavy" cells, biosynthetically poised for proliferation and memory formation. In patients with melanoma receiving immune checkpoint blockade, pre-treatment buoyant mass profiling of circulating T cells predicted therapeutic response with an accuracy comparable with standard tumor-derived biomarkers. Our findings establish buoyant mass as a label-free, stimulation-independent measure of systemic T cell fitness, providing a rapid and broadly applicable framework for immune profiling and response prediction in cancer and beyond.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma
Ye Zhang, Lydie L. Debaize, … Mark Alan Murakami·Science AdvancesPeer-reviewed·Dec 5, 2025
- B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
J. Griss, W. Bauer, … S. N. Wagner·bioRxiv·Jan 10, 2019
- Spatial organization and stochastic fluctuations of immune cells impact clinical responsiveness to immune checkpoint inhibitors in patients with melanoma
G. Giuliani, W. Stewart, … J. Das·bioRxiv·Dec 6, 2023
- Sensitivity to Immune Checkpoint Blockade and Progression-Free Survival is associated with baseline CD8+ T cell clone size and cytotoxicity
R. A. Watson, O. Tong, … B. P. Fairfax·bioRxiv·Nov 15, 2020
- A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors
T. Yamauchi, T. Hoki, … F. Ito·bioRxiv·Jun 13, 2020
- Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types